Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology

Brain Research

Volumn 796, Issue 1-2, 1998, Pages 209-221

  Kurumatani, Takahiro ^a   Fastbom, Johan ^a   Bonkale, Willy L ^a   Bogdanovic, Nenad ^a   Winblad, Bengt ^a   Ohm, Thomas G ^b   Cowburn, Richard F ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Autoradiography; Hippocampus; Human brain Alzheimer's disease; Inositol 1,3,4,5 tetrakisphosphate; Inositol 1,4,5 trisphosphate; Neurofibrillary tangles; Phorbol 12,13 dibutyrate; Protein kinase C; Staging

Indexed keywords

AMYLOID; INOSITOL 1,3,4,5 TETRAKISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PROTEIN KINASE C;

ALZHEIMER DISEASE; ARTICLE; AUTORADIOGRAPHY; CEREBELLUM; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SUBICULUM;

EID: 0032526841     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00347-3     Document Type: Article

References (47)

1. Adamec E., Mercken M., Beerman M.L., Didier M., Nixon R.A. Acute rise in the concentration of free cytoplasmic calcium leads to dephosphorylation of the microtubule-associated protein tau. Brain Res. 757:1997;93-101.
2. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders. 3rd edn., revised. Washington, DC, American Psychiatric Association (1987).
3. Blennow K., Cowburn R.F. The neurochemistry of Alzheimer's disease. Acta. Neurol. Scand. 168:1996;77-86. (Suppl.).
4. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. (Berl.). 82:1991;239-259.
5. Braak H., Braak E. Evolution of the neuropathology of Alzheimer's disease. Acta. Neurol. Scand. 165:1996;3-12. Suppl.
6. Buxbaum J.D., Gandy S.E., Cicchetti P., Erlich M.E., Czernik A.J., Fracasso R.P., Ramabhadran T.V., Unterbeck A.J., Greengard P. Processing of Alzheimer β/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6003-6006.
7. Buxbaum J.D., Ruefli A.A., Parker C.A., Cypess A.M., Greengard P. Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4489-4493.
8. Caporaso G.L., Gandy S.E., Buxbaum J.D., Ramabhadran T.V., Greengard P. Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3055-3059.
9. Cole G., Dobkins K.R., Hansen L.A., Terry R.D., Saitoh T. Decreased levels of protein kinase C in Alzheimer brain. Brain Res. 452:1988;165-174.
10. Cressman C.M., Mercken M.M., Shea T.B. Alteration in tau antigenicity and electrophoretic migration by PKCα under cell-free conditions. Neurosci. Res. Commun. 17:1995;61-64.
11. Crews F.T., Kurian P., Freund G. Cholinergic and serotonergic stimulation of phosphoinositide hydrolysis is decreased in Alzheimer's disease. Life Sci. 55:1994;1993-2002.
12. Emmerling M.R., Moore C.J., Doyle P.D., Carroll R.T., Davis R.E. Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein. Biochem. Biophys. Res. Commun. 197:1993;292-297.
13. 2 hydrolysis in Alzheimer's disease Life Sci. 53:1993;439-444.
14. Fleming L.M., Johnson G.V.W. Modulation of the phosphorylation state of tau in situ: the roles of calcium and cyclic AMP. Biochem. J. 309:1995;41-47.
15. 1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies. Ann. Neurol. 29:1991;256-262.
16. 4 binding in Alzheimer's disease brain Brain Res. 681:1995;160-166.
17. Geary W.A., Toga G.F., Wooten G.F. Quantitative film autoradiography for tritium: methodological considerations. Brain Res. 337:1985;99-108.
18. Gong C.-X., Singh T.J., Grundke-Iqbal I., Iqbal K. Alzheimer's disease abnormally phosphorylated τ is dephosphorylated by protein phosphatase-2B (calcineurin). J. Neurochem. 62:1994;803-806.
19. Gong C.-X., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A. Neuroscience. 61:1994;765-772.
20. Gong C.-X., Shaikh S., Wang J.-Z., Zaidi T., Grundke-Iqbal I., Iqbal K. Phosphatase activity toward abnormally phosphorylated τ: decrease in Alzheimer disease brain. J. Neurochem. 65:1995;732-738.
21. qα, phospholipase C, and protein kinase C in post mortem human brain: Effects of post mortem interval, subject age, and Alzheimer's disease. Neuroscience. 69:1995;125-138.
22. Grynspan F., Griffin W.R., Cataldo A., Katayama S., Nixon R.A. Active-site directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res. 763:1997;145-158.
23. Haug L.S., Østvold A.C., Cowburn R.F., Garlind A., Winblad B., Bogdanovic N., Walaas S.I. Decreased inositol(1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severity. Neurodegeneration. 5:1996;169-176.
24. 3H] phorbol 12,13-dibutyrate binding to protein kinase C in Alzheimer's disease J. Neurochem. 56:1991;1121-1129.
25. H.-M. Huang, R. Martins, S. Gandy, R. Etcheberrigaray, E. Ito, D.L. Alkon, J.P. Blass, G.E. Gibson, The use of cultured fibroblasts in elucidating the pathophysiology and diagnosis of Alzheimer's disease, in: J.F. Disterhoft, W.H. Gispen, J. Traber, Z.S. Khachaturian (Eds.), Calcium Hypothesis of Aging and Dementia, New York: New York Acad. Sci., 747 (1994) 225-244.
26. Jope R.S., Song L., Li X., Powers R. Impaired phosphoinositide hydrolysis in Alzheimer's disease brain. Neurobiol. Aging. 15:1994;221-226.
27. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch. Neurol. 42:1985;1097-1105.
28. 3H] inositol(1,3,4,5)tetrakisphosphate binding sites in human brain J. Neural Transm. 104:1997;175-189.
29. 1 muscarinic receptor-G-protein coupling in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 54:1995;783-789.
30. Lovestone S., Reynolds C.H., Latimer D., Davis D.R., Anderton B.H., Gallo J.-M., Hanger D., Mulot S., Marquardt B., Stabel S., Woodgett J.R., Miller C.J. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4:1994;1077-1086.
31. Lovestone S., Reynolds C.H. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience. 78:1997;309-324.
32. Masliah E., Cole G., Shimohama S., Hansen L., DeTeresa R., Terry R.D., Saitoh T. Differential involvement of protein kinase C isozymes in Alzheimer's disease. J. Neurosci. 10:1990;2113-2124.
33. Masliah E., Cole G.M., Hansen L.A., Mallory M., Albright T., Terry R.D., Saitoh T. Protein kinase C alteration is an early biochemical marker in Alzheimer's disease. J. Neurosci. 11:1991;2759-2767.
34. 2+-independent protein kinase C changes in the brains of patients with Alzheimer's disease. J. Neurochem. 67:1996;317-323.
35. McKahnn G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
36. Nixon R.A., Saito K.-I., Grynspan F., Griffin W.R., Katayama S., Honda T., Mohan P.S., Shea T.B., Beerman M. Calcium-activated neutral protease (calpain) system in aging and Alzheimer's disease. Ann. New York Acad. Sci. 747:1994;77-91.
37. Ohm T.G., Braak E., Bohl J., Braak H. A competition between silver-stain and immunocytochemistry. J. Neural. Transm. 1:1989;111. [P-D section].
38. 3H] phorbol ester binding sites in Alzheimer's and Parkinson's disease: an autoradiographic study, in: B. Corain, K. Iqbal, M. Nicolini, B. Winblad, H. Wisniewski, P. Zatta (Eds.), Alzheimer's Disease: Advances in Clinical and Basic Research, Wiley, 1993, pp. 341-348.
39. Pearson R.C.A., Powell T.P.S. The neuroanatomy of Alzheimer's disease. Rev. Neurosci. 2:1989;101-122.
40. Pei J.J., Tanaka T., Tung Y.C., Braak E., Iqbal K., Grundke-Iqbal I. Distribution, levels and activity of glycogen synthase-3 in the Alzheimer disease brain. J. Neuropathol. Exp. Neurol. 56:1997;70-78.
41. Querfurth H.W., Selkoe D.J. Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry. 33:1994;4550-4561.
42. Shimohama S., Narita M., Matsushima H., Kimura J., Kameyama M., Hagiwara M., Hidaka H., Taniguchi T. Assessment of protein kinase C isozymes by two-site enzyme immunoassay in human brains and changes in Alzheimer's disease. Neurology. 43:1993;1407-1413.
43. Slack B.E., Nitsch R.M., Livneh E., Kunz G.M. Jr., Breu J., Eldar H., Wurtman R.J. Regulation by phorbol esters of amyloid precursor protein release from Swiss 3T3 fibroblasts overexpressing protein kinase Cα J. Biol. Chem. 268:1993;21097-21101.
44. Smith C.J., Perry E.K., Perry R.H., Fairbairn A.F., Birdsall N.J.M. Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain - a preliminary study in Alzheimer's disease. Neurosci. Lett. 82:1987;227-232.
45. Wang H.-Y., Pisano M.R., Friedman E. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain. Neurobiol. Aging. 15:1994;293-298.
46. Wolf B.A., Wertkin A.M., Jolly Y.C., Yasuda R.P., Wolfe B.B., Konrad R.J., Manning D., Ravi S., Williamson J.R., Lee V.M. Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid β-protein production in human neuronal NT2N cells. J. Biol. Chem. 270:1995;4916-4922.
47. 3H] inositol1,4,5-trisphosphate binding in Alzheimer's disease Neurosci. Lett. 94:1988;198-202.